Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Rivoli

14 clinical trials in Rivoli, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Rivoli at a glance
14
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

14 trials in Rivoli

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:ECRI-trials B.V.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Insel Gruppe AG
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Fondazione Toscana Gabriele Monasterio
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Jazz Pharmaceuticals Ireland Limited
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Azienda Ospedaliera Universitaria Gaetano Martino Messina

Arteriosclerosis

Not yet recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Iodide
  • Sponsor:Faraday Pharmaceuticals Inc.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Rivoli

What the registry says about research in the country

01 Myocardial Infarction Research

Clinical studies focusing on innovative treatments for patients with acute myocardial infarction, evaluating new therapeutic compounds and interventions to improve outcomes after heart attacks.

  • Novel drug therapies assessment
  • Post-heart attack treatment optimization
  • Cardiovascular mortality reduction

Multiple trials are investigating both immediate and long-term therapeutic approaches for heart attack patients.

02 Coronary Care Studies

Research examining various antiplatelet therapy strategies in patients with acute coronary syndrome, particularly focusing on optimizing treatment regimens after stent implantation.

  • Antiplatelet medication optimization
  • Bleeding risk management
  • Stent-related treatments

These trials aim to balance therapeutic effectiveness with patient safety in coronary interventions.

03 Cardiac Rhythm Management

Innovative studies addressing treatment approaches for patients with atrial fibrillation, including left atrial appendage closure procedures and antithrombotic therapy optimization.

  • Device-based interventions
  • Anticoagulation strategies
  • Bleeding prevention protocols

Research focuses on developing safer and more effective treatment protocols for cardiac rhythm disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.